Document is current
Any future updates will be listed below
-
Authors
Uraki, Ryuta https://orcid.org/0000-0003-0890-1922
Kiso, Maki
Imai, Masaki https://orcid.org/0000-0001-6988-1975
Yamayoshi, Seiya https://orcid.org/0000-0001-7768-5157
Ito, Mutsumi
Fujisaki, Seiichiro
Takashita, Emi https://orcid.org/0000-0002-9064-4699
Ujie, Michiko
Furusawa, Yuri
Yasuhara, Atsuhiro
Iwatsuki-Horimoto, Kiyoko https://orcid.org/0000-0002-8266-020X
Sakai-Tagawa, Yuko
Watanabe, Shinji
Hasegawa, Hideki
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21fk0108615)
Japan Agency for Medical Research and Development (JP20fk0108472)
Japan Agency for Medical Research and Development (JP20nk0101632)
Japan Agency for Medical Research and Development (JP21wm0125002)
Japan Agency for Medical Research and Development (JP20fk0108412)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201400008C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
- License Information
-
More Information
Article History
Received: 7 January 2022
Accepted: 1 June 2022
First Online: 15 June 2022
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. LTD, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation and Fuji Rebio. All other authors declare no competing interests.
Free to read: This content has been made available to all.
